Localized Prostate Cancer Clinical Trial
Official title:
Safety and Efficacy Study of Hypofractionated Radiotherapy for Localized Prostate Cancer: a Single-arm Clinical Trial
The aim of this trial is to study the safety outcomes of hypofractionated radiotherapy in treating patients with localized prostate cancer. Hypofractionated radiotherapy delivers higher doses of radiotherapy in a shorter time period, may enabling the killing of more tumor cells with fewer side effects. Accumulating evidence has proven the safety and feasibility of hypofractionated radiotherapy for localized prostate cancer.But for localized prostate cancer,the optimal dose per fraction of hypofractionated radiotherapy is still on its way.
The present study will be conducted as a prospective, open-label, single-arm clinical trial. The patients will receive hypofractionated radiation(54 Gy in 15 daily fractions of 3.6 Gy ). After completion of study treatment, patients were followed up once a month for the first 3 months and once every 3 months after 3 months for a total of 5 years. The primary endpoints of the study are the toxicities about gastrointestinal (GI),genitourinary (GU) symptoms and erectile dysfunction.The secondary endpoints include progression-free survival (bPFS), local progression-free-survival(LPFS) ,distant metastasis free survival(DMFS) ,overall survival (OS)and quality of life (QoL). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03996005 -
MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
|
N/A | |
| Withdrawn |
NCT02159690 -
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
|
Phase 2 | |
| Completed |
NCT00196781 -
Treatment Decision Making in Early-Stage Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT03821246 -
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
|
Phase 2 | |
| Active, not recruiting |
NCT03814252 -
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer
|
N/A | |
| Completed |
NCT01931046 -
Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT01714219 -
Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy
|
N/A | |
| Active, not recruiting |
NCT03315754 -
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
|
Phase 2 | |
| Recruiting |
NCT05010343 -
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06325995 -
Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
|
N/A | |
| Recruiting |
NCT06051942 -
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
|
N/A | |
| Completed |
NCT02297386 -
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT06117059 -
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
|
N/A | |
| Withdrawn |
NCT04225299 -
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT06054867 -
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
|
N/A | |
| Active, not recruiting |
NCT02435472 -
Active Surveillance Exercise Clinical Trial
|
N/A | |
| Completed |
NCT00717613 -
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting
|
N/A | |
| Completed |
NCT02662673 -
Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device
|
N/A | |
| Recruiting |
NCT05155046 -
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
|
Phase 2 | |
| Completed |
NCT01902680 -
Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.
|
Phase 2 |